ライフサイエンスコーパス: muscle relaxant

1 inistered with rocuronium, a nondepolarizing muscle relaxant.

2 incomplete as predicted by its efficacy as a muscle relaxant.

3 to labor is prostacyclin (PGI(2)), a smooth muscle relaxant.

4 or to labor is prostacyclin (PGI2), a smooth muscle relaxant.

5 st prior to labor, prostacyclin, is a smooth muscle relaxant.

6 e, we examine cisatracurium, a commonly used muscle relaxant.

7 es in VO2 and VCO2 seen without the use of a muscle relaxant.

8 role in identifying cross-reactivity between muscle relaxants.

9 he pediatric airway has reduced the need for muscle relaxants.

10 antibiotic and anti-inflammatory therapy and muscle relaxants.

11 etylcholine receptors are clinically used as muscle relaxants.

12 ever is impaired by volatile anesthetics and muscle relaxants.

13 d inhalational anaesthetics and depolarising muscle relaxants.

14 ts, prescription proton-pump inhibitors, and muscle relaxants.

15 e most common medication classes were smooth-muscle relaxants (16 trials), bulking agents (13 trials)

16 effects that are probably independent of its muscle-relaxant action.

17 and analgesic agent without centrally acting muscle relaxant activity.

18 in inhibitor), but not hydralazine (a smooth muscle relaxant), ameliorated colitis in RenTgMK mice, a

19 Behaviorally, SH-I-048A induced sedative, muscle relaxant and ataxic effects, reversed mechanical

20 n of VO2 following the administration of the muscle relaxant and the observation that turning a patie

21 observed between the sexes, particularly for muscle relaxants and opioids.

22 h potent antimicrobial, vasodilating, smooth muscle relaxant, and growth factor stimulating effects.

23 and surgical needs should dictate the use of muscle relaxants, and alternatives to their use should b

24 e management strategy that avoids sedatives, muscle relaxants, and physical restraints, and allows li

25 ues surrounding ECT, cardiac effects, use of muscle relaxants, and the consent process.

26 (BZ) site produces the sedative, anxiolytic, muscle relaxant, anticonvulsant and cognition-impairing

27 d to the discovery of the nonsedating potent muscle relaxant, antiinflammatory, and analgesic agent (

28 This paper describes the synthesis and the muscle relaxant, antiinflammatory, and analgesic structu

29 Nonsteroidal anti-inflammatory drugs and muscle relaxants are a very effective combination for th

30 Short-acting and low doses of medium-acting muscle relaxants are appropriate for the typically short

31 Smooth-muscle relaxants are beneficial when abdominal pain is t

32 Skeletal muscle relaxants are effective for short-term pain relie

33 Muscle relaxants are still indicated for intubation and

34 esthetic drugs (inhalational anesthetics and muscle relaxants) are described.

35 of CHZ, which is currently FDA approved as a muscle relaxant, as a safe and novel treatment of EA2.

36 nt/anxiolytic activity but was devoid of the muscle relaxant/ataxic effects of "classical" 1,4-benzod

37 nce the discovery of the GABA(B) agonist and muscle relaxant baclofen, there have been substantial ad

38 epinalone; the antiemetic benzquinamide; the muscle relaxant cyclobenzaprine; the analgesic nefopam;

39 nodine receptor (RYR) channels, the skeletal muscle relaxant dantrolene has proven to be both a valua

40 The skeletal muscle relaxant dantrolene inhibits the release of Ca2+

41 In tracheal intubation, the use of muscle relaxants decreases laryngospasm.

42 ent role and factors affecting the choice of muscle relaxant drugs in pediatric anesthesia.

43 controlled trials concluded that the smooth muscle relaxant drugs tamsulosin and nifedipine assisted

44 muscarinic and anticholinergic/direct smooth muscle relaxant drugs.

45 cting at sites in the MRF would be effective muscle relaxants during pregnancy, prior to the fall in

46 thetic drugs has reduced the requirement for muscle relaxants during surgery.

47 he discovery of the potent, centrally acting muscle relaxant (E)-2-(4,6-difluoro-1-indanylidene)aceta

48 ployed in the study suggests that the smooth muscle relaxant effects of heptanol may be non-specific

49 ack pain are NSAIDs, acetaminophen, skeletal muscle relaxants (for acute low back pain), and tricycli

50 vidence that NSAIDs, acetaminophen, skeletal muscle relaxants (for acute low back pain), and tricycli

51 once the effects of the intubating dose of a muscle relaxant have worn off.

52 Treatment with a muscle relaxant impairs mouth opening, supporting the hy

53 t peptide, SMP) was recently identified as a muscle relaxant in the starfish Patiria pectinifera.

54 anesthetic drugs have influenced the use of muscle relaxants in children.

55 es are a family of neuropeptides that act as muscle relaxants in echinoderms.

56 t evidence for efficacy was shown for smooth-muscle relaxants in patients with abdominal pain as the

57 actice have reduced or obviated the need for muscle relaxants in pediatric anesthesia.

58 agents may improve upon currently available muscle relaxants in terms of rapid onset, short duration

59 were abolished in all regions by the smooth muscle relaxants isoproterenol (1 microM), nicardipine (

60 rugs were incriminated: antibiotics (49.6%), muscle relaxants, latex and anesthetics (15%), nonsteroi

61 teroidal anti-inflammatory drugs or skeletal muscle relaxants (moderate-quality evidence).

62 y drugs, acetaminophen, opioids, or skeletal muscle relaxants, often in combination.

63 on (analgesics, antiinflammatory agents, and muscle relaxants) (P< 0.001) and used less physical ther

64 eptor block with the reversible, competitive muscle relaxant, pancuronium.

65 Administration of a vascular smooth muscle relaxant prevented onset of myocardial necrosis.

66 hese isoforms is thought to determine smooth muscle-relaxant properties and unique responses to signa

67 do not play a key role in the anxiolytic and muscle-relaxant properties of benzodiazepine-type drugs;

68 Only nondepolarizing muscle relaxants should be used in patients who are at r

69 During ambulatory anesthesia, muscle relaxants should be used judiciously because of t

70 halation anesthetics and/or the depolarizing muscle relaxant succinylcholine in malignant hyperthermi

71 lected by their increased sensitivity to the muscle relaxant succinylcholine.

72 mice were treated with hydralazine (a smooth muscle relaxant), the blood pressure was normalized but

73 intubation attempts and laryngoscopic view, muscle relaxant use is an independent predictor of compl

74 Dantrolene is a skeletal muscle relaxant which acts by inhibiting intracellular C

75 Because the muscle relaxant zoxazolamine is a known substrate for CY